Compare NAUT & PFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NAUT | PFL |
|---|---|---|
| Founded | 2016 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Finance Companies |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 383.5M | 371.7M |
| IPO Year | 2020 | 2003 |
| Metric | NAUT | PFL |
|---|---|---|
| Price | $3.27 | $8.00 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | ★ 372.8K | 274.3K |
| Earning Date | 04-28-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.53% |
| EPS Growth | ★ 16.07 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $992.86 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.62 | $7.60 |
| 52 Week High | $4.31 | $8.70 |
| Indicator | NAUT | PFL |
|---|---|---|
| Relative Strength Index (RSI) | 52.34 | 49.05 |
| Support Level | $1.93 | $7.60 |
| Resistance Level | $4.31 | $8.49 |
| Average True Range (ATR) | 0.42 | 0.13 |
| MACD | -0.03 | 0.04 |
| Stochastic Oscillator | 33.92 | 80.77 |
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its products includes: Proteome Analysis System, Reagent Kits, Software and analysis.
PIMCO Income Strategy Fund is a United States-based closed-end management investment company. The fund's investment objective is to seek high current income, consistent with the preservation of capital. The company seeks to achieve its objectives by investing in a diversified portfolio of floating and fixed-rate debt instruments.